STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,372 | -83.9% | 13,800 | -62.3% | 0.00% | -100.0% |
| Q4 2022 | $337,818 | +2.7% | 36,600 | +43.0% | 0.00% | 0.0% |
| Q3 2022 | $329,000 | +33.7% | 25,600 | +37.6% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -37.6% | 18,600 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $394,000 | -59.0% | 18,700 | -53.2% | 0.00% | -50.0% |
| Q4 2021 | $960,000 | -53.5% | 40,000 | -50.7% | 0.00% | -60.0% |
| Q3 2021 | $2,063,000 | +28.8% | 81,100 | +70.4% | 0.01% | +25.0% |
| Q2 2021 | $1,602,000 | +67.7% | 47,600 | +93.5% | 0.00% | +33.3% |
| Q1 2021 | $955,000 | – | 24,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |